CC-401 is a second generation ATP-competitive anthrapyrazolone JNK (c-Jun N terminal kinase) inhibitor with potential antineoplastic activity.
See how others have used CC-401. Click on the entry to view the PubMed entry .
PMID: # 30190333 Insua-Rodríguez, J.|Pein, M.|Hongu, T.|Meier, J.|Descot, A.|Lowy, CM.|De Braekeleer, E.|Sinn, HP.|Spaich, S.|Sütterlin, M.|Schneeweiss, A.|Oskarsson, T.| et al. 2018. EMBO Mol Med. 10:
PMID: # 26134322 Evason, KJ. et al. 2015. PLoS Genet. 11: e1005305.
PMID: # 26058558 Zhang, H. et al. 2015. Journal of medical virology. 87: 2135-44.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.